Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good morning MVES. This is thin. I think it's only a matter of time before we see a move on MVES. The chart shows that this is ready to move in the next few days .
Great article
?https://www.otcmarkets.com/stock/ARNH/video-and-presentations $arnh corporate audio update! ?
Starting to stack up and look pretty good for a bounce imo
L2 is super thin. This will move back over a penny in the next week or so
Can't wait to hear more about the Cancer Drug and medical device.
The stock was halted because of his mistatements and late filings over a year ago. The stock was pink current/yield when it was halted. James had been the CEO for over a year when the stock was halted. He was the reason it was halted and then subsequently grey sheeted. He's made statements in the past in press releases on his website about prior management being to blame for being halted but, it's hard to believe that when youve been the CEO of over a year.
Though I see your point I disagree on your statement about the sec not being able to touch someone for lying just because they're on the grey market. They can't exactly halt the stock or grey sheet it again.
But, james l Robinson can be charged for misstatement and be charged for fraud and for running a pump n dump (back when it actually was trading)
Good news today after that MONSTER news yesterday. Let's go SANP
Nice news and nice progress. Moving forward. :)
Yunnan Hemp is 50% owned by the Chinese government!!!! Awesomeness
I think you could be right. Spread the word!
Adding here myself
Good morning all!
?$SANP news out. huge MOU signed by largest licensed provider of cannabis/Hemp in China. Yunnan Hemp. Cnhemp.com https://www.otcmarkets.com/financialReportViewer?symbol=SANP&id=175488?
Yunnan Hemp is the largest licensed provider of cannabis Hemp in china. Yunnan Hemp is 50% owned by the government of china. This is perhaps the largest deal china has ever signed with a US company in regards to cannabis.
This MOU is with the largest provider of cannabis Hemp in china and is 50% owned by the government of china
?$SANP news out. huge MOU signed by largest licensed provider of cannabis/Hemp in China. Yunnan Hemp. Cnhemp.com
https://www.otcmarkets.com/financialReportViewer?symbol=SANP&id=175488?
Did you read the press release? The CEO says 1 for 1
You can't do a reverse split on a skull and cross bones grey sheet.
The company will either have to raise authorized shares for this or James l Robinson is a liar. A 3rd option could be that he doesn't know what he's talking about. But that's not an attractive scenario either.
True... part of the agreement according to the press release was that FITX shareholders will get shares on a 1-1 basis. With all the debt owed to debtholders in FPFI that will mean that the authorized shares will need to be raised to roughly 10billion or so as FITX outstanding shares was 4.5 billion roughly.
Not a good deal for anyone.
Not sure who those guys are. The info has been spread around and shared on twitter, ihangout, stock twits and many Facebook groups.
He still owns the shares but is no longer on the board. Which means he can convert and sell whenever as he is no longer and insider.
Yep, that looks really good. I'm interested to see how this plays out. I hope we get further details when the deal gets closed.
He committed Fraud by deception. Wire fraud. Stole 160k through embezzlement from shareholders/debt holders. Money was to be used to get previous ticker trading, to pay otc markets and Nevada and to launch the energy drink.... over a year ago. Still none of that has been done.
Canouse Family and ACAP financial/Joe Poe
Google any of those names. And look at the history of James's former company that trades under creative edge nutrition and you'll see that the guy is in some deep trouble with the SEC.
Warning in regards to merger CEO James L Robinson.
James was fired from the company a few weeks before james vended out. Illegal action by a CEO.
He is also facing civil and legal charges.
"the debt holders have sent a formal demand letter to James outlining the following requirements:
1) You resign your position(s) as an Officer and as a director of Creative Edge; and,
2) Transfer the Super Voting Rights preferred shares transferred to you as CEO in order to maintain control over the Company; and,
3) Transfer the trademark and any other mark or intellectual property belonging to Creative; and,
4) Pay back the $130,000.00 Investment from the Group, as well as the total amount of money expended by the Group to the State of Nevada and the OTC, as well as other costs expended to cure the company’s filing delinquencies; and
5) Returning to the Company any shares of common stock you obtained or gifted unlawfully; and
6) Obtain the resignation of every other present Officer and Director of Creative Edge.
The full demand letter will become public over the next few weeks, along with any potential resolution. We have, in our possession, backup documentation that proves every allegation that shareholders have put forward.
Again, thanks to all shareholders for their commitment to Creative Edge Nutrition. We continue to work hard on your behalf."
FPFI owners are currently backing out of the merger deal due to james not disclosing he was under investigation and civil suit.
Www.cnhemp.com
Yunnan Hemp is the largest Hemp company in China. 50% owned by the Chinese government. This is HUGE!
James l Robinson comes with a lot of baggage. He is seriously in major trouble with the SEC
If he hasn't then perhaps someone should inform the owners of the shell of the legal troubles james has and the many many many lawsuits coming as well as criminal charges.
Has james disclosed to the company his legal troubles?
James l Robinson literally Stealing investors money as well.
Great day today for MVES. Nice volume and nice Green Day.
Yep, 6 pods sold at 40k is 240k in a month. If that level of production keeps up then that's roughly 3 million a year in revenues. That's HUGE!
$sanp
https://finance.yahoo.com/news/podwerks-finishes-qa-first-pod-114500074.html
$sanp news just released. 6 pods sold at $40k a piece in less than a month! That's 240 grand a month in revenues.
I've got a good feeling about this trip that the CEO is taking. I think we should hear from the company very soon.
SeeThruEquity Initiates Coverage on Earth Science Tech, Inc. (OTC PINK: ETST) with a Price Target of $4.12
NEW YORK, NY / ACCESSWIRE / June 28, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has initiated coverage on Earth Science Tech, Inc. (OTC PINK: ETST) with a price target of $4.12.
The report is available here: ETST Initiation Report.
Earth Science Tech is a biotechnology company focused on research, development, and sale of hemp derived CBD based nutraceuticals, pharmaceuticals and dietary supplements. CBD is one of the more than 85 cannabinoids identified in marijuana and hemp plants and is non-psychoactive with a wide array of therapeutic benefits. Hemp derived CBD market is projected to grow at a CAGR of ~53% till 2020, positioning it as the fastest growing sub segment within the multi-billion-dollar legal cannabis and hemp market. The recent launch of new flavored CBD oil, organic chocolate CBD line, and pet CBD is expected to boost revenues this year. The JV partnership with Karmavore Superfoods and Forzagen provides ETST with an entry in the lucrative multi-billion dollar sports supplement market and food edibles. Further, the recent new formed wholly owned subsidiary of KannaBidioiD, Inc. diversifies ETST's presence in the niche recreational vape/smoke space. Heavy marketing push via presence in high profile magazines (Natural Awakenings) and web portals (MassRoots) is expected to yield strong order flow going forward. The product pipeline remains robust with series of CBD based nutraceutical being on of the two only CBD companies that recommended by the Institute of Natural Healing (INH) for cancer as well two CBD generic pharmaceuticals, two medical devices (MSN-2), and three patent pending products based off their application claims the benefit of ETST U.S. Provisional Application N. 62/061,577, filed October 8, 2014 and ETST U.S. Provisional Application No. 62/102,538, filed January 12, 2015 anticipated to be launched in 2H17 and early 2018. We see ETST as a speculative play on the burgeoning legal cannabis and hemp market targeting the fastest growing sub segment (hemp derived CBD). Going forward in FY17, we expect ETST to increase revenues approximately 350% to $2 million through new product launches, aggressive marketing initiatives and entry into new markets (sports supplement, recreational vape/smoke).
Highlights from the report include:
Large addressable market opportunity
CBD pharmaceuticals and nutraceuticals are one of the fastest growing sectors in the legal cannabis industry. Clinical research studies have demonstrated that CBD nutraceuticals have the potential to treat arthritis, MS, chronic pain, PTSD, depression, epilepsy and a myriad of other illnesses and disorders. The North American legal cannabis market stood at ~$7 billion in 2016, with strong growth prospects. The market is expected to reach ~$22 billion by 2020, representing a CAGR of 25%. Eight states in the US have legalized the use of recreational marijuana (cannabis), while 29 states allow marijuana to be used for medicinal purpose. We believe favorable regulatory environment will provide further tailwind to ETST. However, the recent stance by DEA that it considers CBD as a Schedule 1 substance has created some overhang.
Strong product pipeline to fuel growth
The product pipeline remains robust with series of CBD based nutraceutical, supplements as well pharmaceutical products anticipated to be launched in 2Q17 and early 2018. The pipeline comprises three sports supplements to be launched in 2017, two CBD based pharmaceuticals drugs to be launched in 1Q/2Q18, new e-liquid and edible gummies from it's newly formed subsidiary to be launched 3Q/2017, and three patent pending CBD based nutraceuticals to be launched by the end of the calendar year 2017.
New product launches to provide fillip to revenues
The recent launch of new flavored CBD oil (Orange Blossom), organic chocolate CBD line, and pet CBD is expected to boost revenues this year. The initial sales of organic chocolates developed in partnership with Karmavore Superfood have been selling rapidly with great excitement and feedback from store owners and customers. The sample test studies conducted by ETST point to Orange Blossom being the best tasting CBD oil available, and the company foresee it being a huge hit.
New strategic partnerships and aggressive marketing push to yield strong order flow
The strategic partnerships with Karmavore Superfood, Forzagen and Smart Medicines will help ETST to diversify product offerings and accelerate entry in new markets. ETST is aggressively spending on marketing via presence in high profile magazines (Natural Awakenings), web portals (MassRoots), and one of the tow only CBD companies recommended by the Institute of Natural Healing (INH) for cancer. We believe these initiatives will help ETST reach more users, gain major brand recognition, and build early demand for its innovative new products.
Initiate coverage with a price target of $4.12
We see ETST as a high risk and high reward play on the burgeoning legal cannabis and hemp industry, targeting the fastest growing sub segment (hemp derived CBD). The target of $4.12 assumes that the company is successful in executing its growth strategy revolving around new product launches, strategic partnerships and aggressive marketing campaigns. Key risks includes any adverse regulatory stance that could materially damage company growth prospects.
Please review important disclosures on our website at www.seethruequity.com.
About Earth Science Tech, Inc.
Earth Science Tech Inc. is a unique Biotechnology company focused on cannabinoid based nutraceuticals, pharmaceuticals and dietary supplements for use in the areas of health, wellness, sports and alternative medicine. It sells its products through its distributors, retail stores and through the Internet. The company comprises of three wholly owned subsidiaries including Cannabis Therapeutics Inc., Earth Science Pharmaceuticals Inc. and Kannabidioid Inc. For more information, visit www.earthsciencetech.com.
About SeeThruEquity
Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion.
SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry's most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.
For more information visit www.seethruequity.com.
Contact:
Ajay Tandon
SeeThruEquity
info@seethruequity.com
SOURCE: SeeThruEquity
© 2017 ACCESSWIRE
Diesen Artikel bookmarken bei ...
80% increase in profit over previous year....
Anyone here can see that there was an increase in sales over the previous year by 80%. But that doesn't fit some people's MO.
tell Paul hello
Beautiful news out today. :)